✦ LIBER ✦

408 A phase II study of erlotinib in combination with cisplatin in patients with recurrent or metastatic squamous cell cancer of the head and neck (PHL-002e/NCIC CTG IND.157)

✍ Scribed by E. Winquist; D. Soulieres; E. Chen; M. Tsao; M. Klein; G. Pond; J. Dancey; E. Eisenhauer; L.L. Siu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of erlotinib (OSI-774)

✍ H. Hirte; A. Oza; K. Swenerton; S.L. Ellard; R. Grimshaw; B. Fisher; M. Tsao; L. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Erlotinib and bevacizumab in patients wi

✍ Ezra EW Cohen; Darren W Davis; Theodore G Karrison; Tanguy Y Seiwert; Stuart J W 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 442 KB

Phase II study of pemetrexed in combinat

✍ Vermorken, J.B.; Licitra, L.; Stöhlmacher-Williams, J.; Dietz, A.; Lopez-Picazo, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 281 KB

907 ORAL A Phase II study of temsirolimu

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB

8574 A phase II study of combination che

✍ Won, Y.W.; Park, Y.H.; Ahn, M.J.; Park, K. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

A phase II study of temsirolimus and erl

✍ Bauman, Julie E.; Arias-Pulido, Hugo; Lee, Sang-Joon; Fekrazad, M. Houman; Ozawa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 496 KB